To include your compound in the COVID-19 Resource Center, submit it here.

SkyePharma slips on revenue warning

Drug delivery company SkyePharma (LSE:SKP; SKYE) was off 4.25p to 65p on Monday on news that revenues for the first

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE